Catalyst Event
Tempus AI Inc (TEM) · Other
From Akros U.S. AI Software TOP4 Plus Index (AUAIS4P)
3/25/2026, 12:00:00 AM
Tempus AI announced a strategic collaboration with Daiichi Sankyo on March 25, 2026, to use its AI models for an antibody drug conjugate (ADC) program in oncology.
Korean Translation
템퍼스 AI, 2026년 3월 25일 다이이찌산쿄와 종양학 분야 항체-약물 접합체(ADC) 프로그램에 AI 모델을 활용하는 전략적 협력 발표함
Related Recent Events
Innodata Inc (INOD) · Earnings Release
Innodata's Q1 2026 earnings release is expected.
5/14/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q1 2026 earnings release is scheduled. Analysts forecast EPS of $3.41. Medium importance is estimated as earnings releases typically drive significant volatility scheduled.
5/13/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
As quarterly earnings are key volatility events for growth-stage AI companies, Tempus AI's Q1 2026 earnings release on May 5, 2026, is scheduled
5/5/2026, 12:00:00 AM
ServiceNow Inc (NOW) · Earnings Release
Q1 2026 earnings release is scheduled.
4/22/2026, 12:00:00 AM
Figma Inc (FIG) · Other
Oppenheimer analysts forecast a 'Hold' rating for Figma on March 25, 2026, citing balanced risks from AI competition. Low importance is assigned as a 1% or greater price impact is estimated from the neutral rating; forecasted.
3/25/2026, 12:00:00 AM
Oracle Corp (ORCL) · Other
Oracle announced Fusion Agentic Applications and an expansion of its AI Agent Studio to automate complex business workflows; a price impact of ≥5% is estimated following the expansion of autonomous AI capabilities.
3/24/2026, 12:00:00 AM